科学图书馆
-
The Year in Cardiovascular Medicine 2020: Coronary InterventionM Nicholls. -
Cardiovascular Risk Reduction with Icosapent Ethyl for HypertriglyceridemiaBhatt DL, Steg PG, REDUCE-IT Investigators.
-
Incidence, Predictors, and Outcomes of In-Hospital Percutaneous Coronary Intervention Following Coronary Artery Bypass GraftingF Alqahtani, KM Ziada, V Badhwar et al.
-
Rare Genetic Variants Associated With Sudden Cardiac Death in AdultsAV Khera, H Mason-Suares, D Brockman et al.
-
Influence of LDL-Cholesterol Lowering on Cardiovascular Outcomes in Patients With Diabetes Mellitus Undergoing Coronary RevascularizationME Farkouh , LC Godoy, V Fuster et al.
-
Safety and feasibility of robotic percutaneous coronary intervention: PRECISE (Percutaneous Robotically-Enhanced Coronary Intervention) StudyWeisz G, Metzger DC, Caputo RP et al.
-
Timing and Causes of Unplanned Readmissions After Percutaneous Coronary Intervention: Insights From the Nationwide Readmission DatabaseKwok CS, Shah B, Mamas M et al.
-
Association of CYP2C19 Loss-of-Function Alleles with Major Adverse Cardiovascular Events of Clopidogrel in Stable Coronary Artery Disease Patients Undergoing Percutaneous Coronary Intervention: Meta-analysisM Biswas, SK Kali.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
